Thrombosis Journal (May 2023)

Postoperative intermittent pneumatic compression for preventing venous thromboembolism in Chinese lung cancer patients: a randomized clinical trial

  • Jingyao Li,
  • Aihong Huang,
  • Zhaojie Han,
  • Yi Zhou,
  • Meng Tang,
  • Wei Wu,
  • Shixin Zhang,
  • Kelong Liao,
  • Yihui Xie,
  • Qiao Chen,
  • Xinliang Zou,
  • Shuai Liu,
  • Shuaixiang Gao,
  • Junlong Ren,
  • Qingyuan Xu,
  • Xi Liu,
  • Yi Liao,
  • Tao Jing,
  • WenFeng Tan,
  • Yang Qiu,
  • Haidong Wang

DOI
https://doi.org/10.1186/s12959-023-00498-z
Journal volume & issue
Vol. 21, no. 1
pp. 1 – 10

Abstract

Read online

Abstract Background Postoperative lung cancer patients belong to the high-risk group for venous thromboembolism (VTE). The standardized preventive measures for perioperative VTE in lung cancer are not perfect, especially for the prevention and treatment of catheter-related thrombosis (CRT) caused by carried central venous catheters (CVCs) in lung cancer surgery. Patients and methods This study included 460 patients with lung cancer undergoing video-assisted thoracic surgery (VATS) in our center from July 2020 to June 2021. Patients were randomized into two groups, and intraoperatively-placed CVCs would be carried to discharge. During hospitalization, the control group was treated with low-molecular-weight heparin (LMWH), and the experimental group with LMWH + intermittent pneumatic compression (IPC). Vascular ultrasound was performed at three time points which included before surgery, before discharge, and one month after discharge. The incidence of VTE between the two groups was studied by the Log-binomial regression model. Results CRT occurred in 71.7% of the experimental group and 79.7% of the control group. The multivariate regression showed that the risk of developing CRT in the experimental group was lower than in the control group (Adjusted RR = 0.889 [95%CI0.799–0.989], p = 0.031), with no heterogeneity in subgroups (P for Interaction > 0.05). Moreover, the fibrinogen of patients in the experimental group was lower than control group at follow-up (P = 0.019). Conclusion IPC reduced the incidence of CRT during hospitalization in lung cancer patients after surgery. Trial registration No. ChiCTR2000034511.

Keywords